NEW YORK (GenomeWeb) – Qiagen has entered into a collaboration and comarketing agreement with Centogene, a German firm focusing on genetic diagnosis of rare disease, in an attempt to integrate sample-to-insight research with clinical testing for rare conditions.

The centerpiece of the agreement is the integration of Centogene's CentoMD database of 4.5 million clinically annotated phenotype and genotype variants of rare diseases into the Qiagen Clinical Insight bioinformatics platform and companion knowledge base.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.